Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mary S. Riggins"'
Autor:
Yuesheng Li, Edward J. van Opstal, Paul S. Hoffman, Mary S. Riggins, Glynis L. Kolling, John H. Moore, Richard L. Guerrant, Cirle A. Warren
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:689-696
Antibiotic treatment, including vancomycin, for Clostridium difficile infection (CDI) has been associated with recurrence of disease in up to 25% of infected persons. This study investigated the effects of vancomycin on the clinical outcomes, intesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fbcddaff5b75db78698173b8599b6aa
https://doi.org/10.1128/aac.00877-12
https://doi.org/10.1128/aac.00877-12
Autor:
Edward J. van Opstal, Cirle A. Warren, Glynis L. Kolling, Andrew J. Kennedy, Igor N. Olekhnovich, Michelle Warthan, Timothy L. Macdonald, Richard L. Guerrant, T. Eric Ballard, Paul S. Hoffman, Mary S. Riggins, Xia Wang
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:4103-4111
Clostridium difficile infection (CDI) is a serious diarrheal disease that often develops following prior antibiotic usage. One of the major problems with current therapies (oral vancomycin and metronidazole) is the high rate of recurrence. Nitazoxani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c889edc51316d910ed913eb52b76545d
https://doi.org/10.1128/aac.00360-12
https://doi.org/10.1128/aac.00360-12